Oncodermatology

Sensus Healthcare produces non-invasive devices primarily for the treatment of non-melanoma skin cancers and keloids. Their flagship systems — the SRT-100™ and Sensus SRT Vision™ — are based on Superficial Radiation Therapy (SRT) and Image-Guided SRT (IGSRT).

SRT-Vision

SRT-100

What can be done with Sensus devices:

Treatment of Non-Melanoma Skin Cancers

Basal Cell Carcinoma (BCC)

Squamous Cell Carcinoma (SCC)

Actinic Keratosis

The SRT-100 delivers low-energy, superficial X-rays that precisely target cancer cells near the surface of the skin, offering a non-surgical, cosmetically sensitive alternative — ideal for patients with health risks or lesions in visible or delicate areas.

Treatment of Keloids

Reduces recurrence after surgical removal

Minimizes size and discomfort of existing keloids

Post-excision radiation therapy with the SRT-100 has been proven to significantly reduce recurrence rates from 70–90% down to under 10%.

Image-Guided Superficial Radiation Therapy (IGSRT)

SRT-100 Vision™ integrates high-resolution ultrasound imaging
Allows real-time tumor visualization, depth measurement, and precision targeting
Improves treatment accuracy and patient outcomes

Minimally Invasive, Office-Based Procedure

No cutting, bleeding, or scarring
Well-suited for outpatient settings and dermatology clinics
Typically performed in short sessions over several weeks

SRT-100 Vision (IG-SRT)

The SRT-100 Vision represents the latest advancement in superficial radiotherapy (the only FDA cleared IG-SRT) technology, combining the proven efficacy of the SRT-100 system with advanced high-frequency ultrasound capabilities. This innovative device, developed by Sensus Healthcare, offers enhanced precision and treatment planning, revolutionizing the way dermatological conditions are treated.

SRT-Vision

SRT-100: Leading the Way in Non-Invasive Skin Cancer Treatment

The SRT-100 is a state-of-the-art superficial radiotherapy system designed to provide non-invasive treatment for various dermatological conditions, including basal cell carcinoma, squamous cell carcinoma, and keloids. This advanced medical device delivers targeted radiotherapy directly to the skin’s surface, effectively eliminating cancerous cells while preserving surrounding healthy tissue. The SRT-100 offers a safe, painless, and cosmetically favorable alternative to traditional surgical procedures, making it an ideal choice for patients seeking minimally invasive treatment options.

SRT-100